Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

August 04, 2015 5:04 AM ET

Personal Products

Company Overview of Natraceutical SA

Company Overview

Natraceutical SA develops and manufactures pharmaceutical products for customers in Europe. The company’s structure includes four divisions: Industrial Services Division; Pharma Division; R&D and Regulatory Division; and Biotech Division. The Industrial Services Division provides manufacturing services and out-licensing dossiers of specialized products, such as sterile products for injection, freeze-dried products, and penicillin/cephalosporin antibiotics, as well as topical formulations. The Pharma Division offers products in the fields of dermatology, women's care, respiratory, anti-infectious, pediatrics, and retail consumer healthcare products. The R&D and Regulatory Division engages in ...

Avenue Alcalde Barnils


Edif. A, 1º 3ª

Street Cugat del Vallés

Barcelona,  080174


Founded in 1929


34 93 584 81 85

Key Executives for Natraceutical SA

Natraceutical SA does not have any Key Executives recorded.

Natraceutical SA Key Developments

Natraceutical SA Reports Consolidated Earnings Results for the First Half Ended June 30, 2015

Natraceutical SA reported consolidated earnings results for the first half ended June 30, 2015. For the period, the company reported turnover was EUR 81,493,618 against EUR 79,446,149 a year ago. Operating income was EUR 8,327,843 against EUR 8,163,909 a year ago. Profit before taxes was EUR 8,222,001 against EUR 7,734,963 a year ago. Net result was EUR 7,178,341 against EUR 6,158,167 a year ago.

Natraceutical SA, Q2 2015 Earnings Call, Jul 30, 2015

Natraceutical SA, Q2 2015 Earnings Call, Jul 30, 2015

Reig Jofre Group Wins GBP 230 Million Multiple Awardees Contract for Supplying Generic Pharmaceuticals

Reig Jofre Group won a GBP 230 million multiple awardees contract award from The Secretary of State for Health acting as part of the Crown through the Commercial Medicines Unit (part of the Department of Health) for the supply of generic pharmaceuticals.

Similar Private Companies By Industry

Company Name Region
Air-Val International, S.A. Europe
Johnson & Johnson S.A. Europe
Instituto Espanol SA Europe
Catalysis, S.L. Europe
Proquid SL Europe

Recent Private Companies Transactions

April 8, 2015
Derma UK Ltd

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Natraceutical SA, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at